Serum BDNF discriminates Parkinson’s disease patients with depression from without depression and reflect motor severity and gender differences
Authors:
- 11 November 2020
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 268 (4) , 1411-1418
Abstract
Objective To evaluate the diagnostic value of serum Brain-derived neurotrophic factor (BDNF) levels for discriminating PD with depression from without depression, and to investigate whether serum BDNF levels were associated with motor severity and gender in depressed PD patients. Methods Demographic and clinical data were collected from 122 PD patients with depression, 137 without depression and 110 healthy controls. All participants’ serum BDNF concentrations were measured. Their motor abilities and activity were assessed by the Unified PD Rating Scale Part III (UPDRS III) score and the Hoehn and Yahr (H–Y) stage. Depression was scored using the 17-item Hamilton Rating Scale for Depression (HAMD-17). Associations were analyzed with multivariate regression. Results The serum BDNF levels were lower in depressed PD patients compared to non-depressed PD patients and controls (p < 0.001). The BDNF levels were negatively correlated with UPDRS III score (r = − 0.54, p < 0.001) and H–Y stage (r = − 0.45, p < 0.001). Decreased BDNF levels were associated with women only among depressed PD patients (r = 0.45, p < 0.001). The HAMD-17 score was negatively correlated with BDNF levels (r = − 0.59, p < 0.001), and positively associated with UPDRS III score (r = 0.51, p < 0.001). Multiple regression analysis demonstrated that in the depressed PD patients, female, H–Y stage and UPDRS III score were independent contributors to the BDNF levels (p < 0.001; p = 0.006; p = 0.03, respectively), BDNF and UPDRS III score were independent contributors to HAMD-17 score (p < 0.001, p = 0.01, respectively). Conclusions Decreased serum BDNF levels may be a useful clinical biomarker of depression in PD patients. Serum BDNF may serve as a potential biomarker for motor severity of PD patients with depression, especially in female.Keywords
Funding Information
- National Natural Science Foundation of China (81200970)
This publication has 35 references indexed in Scilit:
- Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological DiseasesBioMed Research International, 2013
- Apathy and depression in Parkinson’s disease: The Belgrade PD study reportParkinsonism & Related Disorders, 2012
- Brain-Derived Neurotrophic Factor and Neuropsychiatric DisordersPharmacological Reviews, 2012
- Maternal serum concentrations of BDNF and depression in the perinatal periodPsychoneuroendocrinology, 2006
- Neurotrophic factors and regulation of mood: Role of exercise, diet and metabolismNeurobiology of Aging, 2005
- Peculiarities of L-DOPA treatment of Parkinson?s diseaseAmino Acids, 2005
- Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neuronsExperimental Neurology, 2005
- Higher incidence of depression preceding the onset of Parkinson's disease: A register studyMovement Disorders, 2003
- Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia NigraExperimental Neurology, 2000
- ParkinsonismNeurology, 1967